Delta Property Fund (DLT) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
31 Jan, 2026Executive summary
Turnaround strategy is gaining momentum despite economic headwinds, high interest rates, and political developments.
Portfolio consists of 89 properties, reducing to 86 post year-end due to strategic disposals, with a focus on the office sector and sovereign tenants.
Emphasis on lease renewals, property disposals, and debt reduction, supported by stakeholder engagement and cost management.
Service quality and property investment maintained despite tight budgets; facilities management and capex prioritized for tenantability.
Portfolio optimization and stakeholder engagement have improved lease expiry profiles and reduced vacancies.
Financial highlights
Profit from operations rose to R399.2 million, a turnaround from a R226.1 million loss in the prior year.
Loss for the period reduced by 89.6% to R77.6 million from R749.7 million.
Portfolio fair value loss decreased to R180.1 million from R833.6 million.
SA REIT FFO per share increased 68.5% to 18.7c.
Overall debt reduced by 48.1% to R183.1 million.
Outlook and guidance
Continued focus on asset disposals, cost containment, and lease renewals to meet covenant levels and return to distributions.
Targeting ZAR 2.3 billion in disposals, with at least 50% unlocking significant interest savings and potential for resuming distributions.
Targeting a post-disposal LTV of 45.0%, debt of R2.0bn, and ICR of 2.0.
Exploring asset repurposing, including office-to-residential conversions.
Plans to evolve into a smaller, more sustainable REIT over the medium term.
Latest events from Delta Property Fund
- Net operating income rose 4.3%, profit fell on fair value losses, and vacancies improved.DLT
H1 202512 Jan 2026 - Profit up 72% as disposals, cost controls, and improved collections drive recovery.DLT
H1 202625 Nov 2025 - Net operating income up 10.3% as disposals, cost control, and debt reduction drive improvement.DLT
H2 202511 Nov 2025